Nov 08, 2021 / 10:00PM GMT
Operator
Hello, and welcome to the Alkermes conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to turn the call over to Alkermes' management. Please go ahead.
Sandra Coombs - Alkermes plc - Co-Head of IR
Welcome. This is Sandy Coombs. Welcome to the Alkermes plc conference call to discuss recent developments related to 2 of our license agreements with Janssen Pharmaceutica. With me today are Richard Pops, our CEO; Iain Brown, our CFO; and Blair Jackson, our Chief Operating Officer.
Our discussions during this conference call will include forward-looking statements. Actual results could differ materially from these forward-looking statements. Please see our press release issued today and our most recent annual report filed with the SEC for important risk factors that could cause our actual results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise the information provided on this call as a result of new information or
Alkermes Plc Investor Update Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot